COMMUNIQUÉS West-GlobeNewswire

Ascendis Pharma A/S Announces Upcoming Investor Presentations

25/04/2018 - 14:30

COPENHAGEN, Denmark, April 25, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company that applies its innovative TransCon technology to address significant unmet [...]

Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals (Up to 32.5 days) and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine

25/04/2018 - 14:30

Patients with a 75% or greater response experienced an eight-fold increase in migraine-free days and more meaningful improvements in bodily pain and physical function BOTHELL, Wash., April 25, 2018 (GLOBE NEWSWIRE) -- [...]

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

25/04/2018 - 14:18

Reference is made to the annual general meeting of Targovax ASA (the "Company") on 11 April 2018 (the "AGM") where election of members to the board of directors was according to the nomination committee's proposal. At [...]

GTX Corp Sponsor and Presenter at the Safe America World Safe Symposium

25/04/2018 - 14:15

Patrick Bertagna GTX Corp CEO nominated to join the Safe America Board LOS ANGELES, April 25, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, [...]

Extendicare Announces Closing of Underwriters' $16.5 Million Over-Allotment Option of 5.00% Convertible Debentures

25/04/2018 - 14:11

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES MARKHAM, Ontario, April 25, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it [...]

Asklepios BioPharmaceutical, Inc. Announces Former Portfolio Company’s Preclinical Asset for Duchenne Muscular Dystrophy Has Advanced into the Clinic

25/04/2018 - 14:05

Pfizer, Inc. Dosed First Patient in its Mini-Dystrophin Gene Therapy Phase 1b Trial Another AskBio Platform Product to be Acquired by Big Pharma Novartis CHAPEL HILL, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- Asklepios [...]

Achaogen to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 4, 2018

25/04/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3

25/04/2018 - 14:00

CHICAGO, April 25, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]

Rick Van Kirk, CEO of Pro-Dex, Inc. Returns to “Stock Day” with Everett Jolly

25/04/2018 - 14:00

PHOENIX, April 25, 2018 (GLOBE NEWSWIRE) -- Pro-Dex, Inc. (NASDAQ: PDEX ) (“Pro-Dex” the “Company”), CEO Rick Van Kirk joined Everett Jolly on “Stock Day” Podcast. “The Company is close to releasing its first Pro-Dex [...]

Cue Biopharma Announces Appointment of Anish Suri, Ph.D. as Chief Scientific Officer

25/04/2018 - 14:00

Dr. Suri’s appointment to senior leadership team adds depth and expertise in immunology and translational studies CAMBRIDGE, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc. (NASDAQ: CUE ), an innovative [...]

Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018

25/04/2018 - 14:00

BRIDGEWATER, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will [...]

Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

25/04/2018 - 14:00

Efficacy and Safety Data in Patients on ZX008 Who Previously Failed Stiripentol Treatment Prior to Entry into First Phase 3 Trial (Study 1) Comparable to Results from Full Study 1 Population Patients on ZX008 Also [...]

Daré Bioscience, Inc. Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform

25/04/2018 - 14:00

The intravaginal ring technology platform is designed to deliver targeted and sustained pharmaceutical formulations addressing unmet needs in women’s health SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience [...]

Adaptimmune to Report First Quarter 2018 Financial Results and Business Update on Wednesday May 9, 2018

25/04/2018 - 14:00

PHILADELPHIA and OXFORD, U.K., April 25, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will announce financial results for the First Quarter 2018 and [...]

PolarityTE, Inc. Regains Compliance With NASDAQ Independent Director Requirement

25/04/2018 - 14:00

SALT LAKE CITY, April 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ) today announced it has received formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") [...]

Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases

25/04/2018 - 14:00

MEDFORD, N.Y., April 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a [...]

Immune Design to Report First Quarter 2018 Financial Results and Provide Corporate Update

25/04/2018 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report [...]

Inovalon Announces First Quarter 2018 Earnings Conference Call

25/04/2018 - 13:55

BOWIE, Md., April 25, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]

Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018

25/04/2018 - 13:31

Press Release 25 April 2018 Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018 Immunicum AB (publ; IMMU.ST) today reported that the annual general meeting (the "AGM") of April 25, 2018 [...]